clinical trial · NCT05591859
Restoration Anatomic Acetabular Shell Revision Study
Stryker Orthopaedics·N/A·recruiting·n = 56
ArthropathyHip ArthropathyHip OsteoarthritisRestoration Anatomic Acetabular Shell
brief summary
This study will be a non-randomized, ambidirectional (retrospective and prospective) study where all subjects will be followed prospectively. The study will evaluate the survivorship of the RAS acetabular component in a previously failed total hip arthroplasty (THA) in a consecutive series of subjects who meet the eligibility criteria.
started
Mar 2, 2024
primary completion
Mar 1, 2036
completion
Mar 1, 2036
last updated
Oct 24, 2025
official title
Restoration Anatomic Acetabular Shell Revision Study - A Post-market, Multi-center Evaluation of the Clinical Outcomes of the Restoration Anatomic Acetabular Shell in a Revision Indication
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol